Latest News & Features
Americas
The US Court of Appeals for the Federal Circuit has blocked US sales of Sandoz’s Zarxio, the biosimilar version of Amgen’s Neupogen, an injection used to prevent infection in patients undergoing chemotherapy. 7 May 2015
Americas
The US Court of Appeals for the Federal Circuit has rejected a man’s claim that he was stopped from entering the fitness machine market because he feared infringing patents that were eventually found to be falsely attributed to Nautilus. 7 May 2015
Americas
Many NPEs have been using their well-stocked war chests to build massive patent portfolios in the medical technology sector, so right owners need to be prepared for a fresh wave of litigation. Jay Nuttall of Steptoe & Johnson offers some tips. 7 May 2015
Americas
The US Supreme Court has rejected pharmaceutical company Bristol-Myers Squibb’s appeal to review a ruling that found its patent covering a treatment for hepatitis B invalid. 6 May 2015
Americas
Law firm Fish & Richardson has added patent attorney Lisa Chiarini to its intellectual property litigation group. 5 May 2015
Biotechnology
For companies that are considering conducting patent litigation around the world, the EPO is a very useful forum for testing their strategy or opposition tactics at a relatively low cost. Hazel Ford and Leythem Wall of Finnegan, Henderson, Farabow, Garrett & Dunner describe the numerous advantages of the procedures available. 30 April 2015
Big Pharma
The English High Court has ruled that a patent covering Novartis’s transdermal patch treatment for Alzheimer’s disease, Exelon, is invalid. 29 April 2015
Americas
A US court has ruled on how five claims in two patents related to acne drug Absorica should be construed, in a patent infringement case between Canada-based Cipher Pharmaceuticals and Actavis. 28 April 2015
Americas
The US Court of Appeals for the Federal Circuit has again found a patent covering a heart rate monitor to be valid, reversing and remanding a district court’s decision for further consideration in the long-running Biosig v Nautilus case. 28 April 2015
Americas
Hedge fund manager Kyle Bass and his Coalition for Affordable Drugs is continuing its campaign against certain pharmaceutical patents, most recently seeking to invalidate patents owned by Celgene and NPS Pharma. 27 April 2015